Forecast: Dengue Fever Vaccines.
By Michael Haydock, Lead Analyst
5 November 2015
I am the Lead Analyst of the immunology and inflammation and infectious diseases and vaccines teams at Datamonitor Healt...
Read full bio
Our latest patient-based forecast estimates the total size of the public sector dengue fever vaccines market within the endemic Latin American and Asia Pacific markets from 2016 to 2025.
The full forecast provides you with estimates of total vaccine sales and vaccinated patient numbers, split by risk group. It also incorporates the anticipated launches of dengue fever vaccines for the immunization of individuals aged 9–30 years.
Fill out the form now to download your exclusive sneak peek into this market leading report >>
If you’re already a subscriber to Datamonitor Healthcare, click here to access the full report.